Naltos™, an innovative and rapid approach to treating breakthrough pain using a novel pain relief peptide
Naltos™,一种使用新型止痛肽治疗突发性疼痛的创新且快速的方法
基本信息
- 批准号:133693
- 负责人:
- 金额:$ 11.33万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Feasibility Studies
- 财政年份:2019
- 资助国家:英国
- 起止时间:2019 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
"Approximately 43% of people in the UK, or around 28 million adults experience pain, which is more than the combined total of those suffering with diabetes, heart disease and cancer. More adults aged 75 or over (62%) experienced pain than those aged 18 to 25 (14.3%) ([https://goo.gl/QvWaW5][0]). Back pain alone costs the NHS £12.3 billion per year; a serious and undertreated condition, uncontrolled pain costs the UK economy far more when considering healthcare expenses, lost income and lost productivity.Analgesics are the frontline therapy for the treatment of cancer pain; however, there has been a recent backlash against opioid-based painkillers, such as fentanyl, due to drug abuse and overdosing. At least 60 drugs deaths in the UK in the past eight months have been linked to fentanyl ([https://goo.gl/iVs1eG][1]).Alchemy Pharmatech is partnering with Nanomerics, specialists in pharmaceutical nanotechnology, to demonstrate feasibility of NaltosTM, a compact, discreet and inexpensive novel intranasal delivery system for quick onset delivery of dry powder-based medications.Successful project delivery will benefit Nanomerics by providing an effective nose-to-brain delivery system for their range of current and future pipeline drugs, thereby enhancing their competitive advantage and increasing revenue and thus, propel both companies in their aim to attract additional funding to develop further products.[0]: https://goo.gl/QvWaW5[1]: https://goo.gl/iVs1eG"
“在英国,大约43%的人,即大约2800万成年人经历过疼痛,这比患有糖尿病、心脏病和癌症的人加起来还要多。75岁或以上的成年人(62%)比18至25岁的成年人(14.3%)有更多的疼痛经历([https://goo.gl/QvWaW5][0]])。仅背痛一项每年就花费NHS 123亿英镑;考虑到医疗费用、收入损失和生产力损失,不受控制的疼痛是一种严重且治疗不足的疾病,对英国经济造成的损失要大得多。镇痛药是治疗癌痛的一线疗法;然而,最近由于药物滥用和过量使用,芬太尼等阿片类止痛药出现了反弹。在过去的8个月里,英国至少有60例毒品死亡与芬太尼有关([https://goo.gl/iVs1eG][1]])。Alchemy Pharmatech正在与制药纳米技术专家Nanomerics合作,以证明NaltosTM的可行性。NaltosTM是一种紧凑、谨慎和廉价的新型鼻内给药系统,用于快速给药干粉类药物。成功的项目交付将使Nanomerics公司受益,为他们目前和未来的药物提供有效的鼻子到大脑的输送系统,从而增强他们的竞争优势,增加收入,从而推动两家公司吸引更多的资金来开发进一步的产品。[0] https://goo.gl/QvWaW5 [1]: https://goo.gl/iVs1eG”
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 11.33万 - 项目类别:
Studentship
相似海外基金
Test, treat, and connect on site using a dual rapid diagnostic point-of-care test for syphilis and HIV among people who are experiencing houselessness
使用梅毒和艾滋病毒双重快速诊断现场检测对无家可归者进行现场检测、治疗和联系
- 批准号:
489125 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Operating Grants
Synthetic Scavenger Medical Countermeasures for Fentanyl
芬太尼的合成清除剂医疗对策
- 批准号:
10726539 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
创新的快速、经济、即时护理 HPV 自检策略 (I-REACH)
- 批准号:
10648634 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
REACHing underserved and undiagnosed populations living with STBBIs to test and link them to care: Implementing innovative clinical trials (iCTs) designs to "test and treat" and bring new rapid point-of-care and self-tests to market in Canada
覆盖服务不足和未确诊的 STBBI 患者,对他们进行测试并将其与护理联系起来:实施创新的临床试验 (iCT) 设计来“测试和治疗”,并将新的快速护理点和自我测试推向加拿大市场
- 批准号:
481601 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Operating Grants
Rapid and efficient generation of sequence variants by templated synthesis
通过模板合成快速有效地生成序列变体
- 批准号:
10726976 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Evaluation and optimization of NWB neurophysiology software and data in the cloud
NWB 神经生理学软件和云数据的评估和优化
- 批准号:
10827688 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Innovative medical device to treat nonunion fracture for older adults
治疗老年人骨折不愈合的创新医疗设备
- 批准号:
10766444 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Mechanoluminescent nanomaterials for optogenetic neuromodulation
用于光遗传学神经调节的机械发光纳米材料
- 批准号:
10616188 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer
MasSpec Pen 技术在非小细胞肺癌术中评估中的验证和转化
- 批准号:
10753977 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Bringing to market an innovative, new mass spectrometer for rapid, robust, and detailed data on all components in complex mixtures
将创新型新型质谱仪推向市场,可快速、可靠且详细地获取复杂混合物中所有成分的数据
- 批准号:
10054996 - 财政年份:2023
- 资助金额:
$ 11.33万 - 项目类别:
Investment Accelerator














{{item.name}}会员




